EBIOPARTICLE-POTENTIATED IMMUNOTHERAPY Trademark Information

Angany Inc.

Chemicals for scientific, laboratory and medical research; chemicals for use in the manufacture of pharmaceuticals; biochemicals, namely, antibodies for scientific, laboratory and medical research; proteins for immunoassay for detection, diagnostic, therapeutic and treatment of cancer, allergies, autoimmune disease, infection diseases

Diagnostic proteins for clinical or medical laboratory analysis; proteins for therapeutic use for treating cancer, allergies, autoimmune disease, infection disease, and inflammatory disease; biopharmaceuticals for use in cancer, allergies, autoimmune disease, infection disease

Development of pharmaceutical preparations and medicines; drug discovery services; pharmaceutical research and development; software as a service (SAAS) provider in the field of vaccinal pharmacologic treatment and allergy medications; platform as a service (PAAS) featuring computer software platforms for use in the field of vaccinal pharmacologic treatment and allergy medications

Vaccinal pharmacologic treatment of autoimmune diseases such as psoriasis, Crohn's disease, rheumatoid arthritis, cancer, infectious diseases and allergies; desensitization treatments for allergy; immunotherapy in the fields of cancer, autoimmune, infectious disease and orphan diseases conditions in humans and veterinary applications; treatment destined to generate in response to its administration in patients the production of the patient's o...

This is a brand page for the EBIOPARTICLE-POTENTIATED IMMUNOTHERAPY trademark by Angany Inc.  in Quebec (Quebec), , G1R1R2.

Write a review about a product or service associated with this EBIOPARTICLE-POTENTIATED IMMUNOTHERAPY trademark. Or, contact the owner Angany Inc. of the EBIOPARTICLE-POTENTIATED IMMUNOTHERAPY trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the EBIOPARTICLE-POTENTIATED IMMUNOTHERAPY trademark.

On Thursday, February 27, 2020, a U.S. federal trademark registration was filed for EBIOPARTICLE-POTENTIATED IMMUNOTHERAPY. The USPTO has given the EBIOPARTICLE-POTENTIATED IMMUNOTHERAPY trademark serial number of 88813300. The current federal status of this trademark filing is NON-FINAL OFFICE ACTION ISSUED - CLARIFICATION NEEDED. The correspondent listed for EBIOPARTICLE-POTENTIATED IMMUNOTHERAPY is PETER KUNIN of DOWNS RACHLIN MARTIN PLLC, 199 MAIN STREET, PO BOX 190, BURLINGTON, VT 05402-0190 . The EBIOPARTICLE-POTENTIATED IMMUNOTHERAPY trademark is filed in the category of Chemical Products , Pharmaceutical Products , Computer & Software Services & Scientific Services , Medical, Beauty & Agricultural Services . The description provided to the USPTO for EBIOPARTICLE-POTENTIATED IMMUNOTHERAPY is Chemicals for scientific, laboratory and medical research; chemicals for use in the manufacture of pharmaceuticals; biochemicals, namely, antibodies for scientific, laboratory and medical research; proteins for immunoassay for detection, diagnostic, therapeutic and treatment of cancer, allergies, autoimmune disease, infection diseases.

Word mark: EBIOPARTICLE-POTENTIATED IMMUNOTHERAPY
Status/Status Date:
NON-FINAL OFFICE ACTION ISSUED - CLARIFICATION NEEDED
5/18/2020
Estimated Response Deadline: 11/18/2020
Serial Number: 88813300
Filing Date: 2/27/2020
Foreign Filing Deadline: Thursday, August 27, 2020
 
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Chemicals for scientific, laboratory and medical research; chemicals for use in the manufacture of pharmaceuticals; biochemicals, namely, antibodies for scientific, laboratory and medical research; proteins for immunoassay for detection, diagnostic, therapeutic and treatment of cancer, allergies, autoimmune disease, infection diseases
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: N/A
Last Applicant/Owner: Angany Inc.
Quebec (Quebec) G1R1R2
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
DOWNS RACHLIN MARTIN PLLC
199 MAIN STREET, PO BOX 190
BURLINGTON, VT 05402-0190

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (001)
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided
Class (044)
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your EBIOPARTICLE-POTENTIATED IMMUNOTHERAPY trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Starting $199/class + govt fees! Click here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner.
Current Trademark Status:
5/18/2020
NON-FINAL OFFICE ACTION ISSUED - CLARIFICATION NEEDED
Correspondent Search:

PETER KUNIN is a correspondent of EBIOPARTICLE-POTENTIATED IMMUNOTHERAPY trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do: